Quick Order

Home>MOG
Text Size:AAA

Myelin oligodendrocyte glycoprotein  Protein, Antibody, ELISA Kit, cDNA Clone

Myelin oligodendrocyte glycoprotein Related Area

Myelin oligodendrocyte glycoprotein Related Pathways

    Myelin oligodendrocyte glycoprotein Related Protein, Antibody, cDNA Gene, and ELISA Kits

    Myelin oligodendrocyte glycoprotein Related Protein, Antibody, cDNA Gene, and ELISA Kits

    Featured Reagent Products

    Myelin oligodendrocyte glycoprotein Summary & Protein Information

    Myelin oligodendrocyte glycoprotein Background

    Subunit structure: Homodimer (By similarity). May form heterodimers between the different isoforms. {ECO:0000250}.
    Subcellular location: Isoform 1: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.; Isoform 5: Cell membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.; Isoform 2: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 3: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 4: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 6: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 7: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 8: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.; Isoform 9: Cell membrane {ECO:0000305}; Single-pass type I membrane protein {ECO:0000305}.
    Tissue specificity: Found exclusively in the CNS, where it is localized on the surface of myelin and oligodendrocyte cytoplasmic membranes.
    Involvement in disease: DISEASE: Narcolepsy 7 (NRCLP7) [MIM:614250]: Neurological disabling sleep disorder, characterized by excessive daytime sleepiness, sleep fragmentation, symptoms of abnormal rapid-eye-movement (REM) sleep, cataplexy, hypnagogic hallucinations, and sleep paralysis. Cataplexy is a sudden loss of muscle tone triggered by emotions, which is the most valuable clinical feature used to diagnose narcolepsy. Human narcolepsy is primarily a sporadically occurring disorder but familial clustering has been observed. {ECO:0000269|PubMed:21907016}. Note=The disease is caused by mutations affecting the gene represented in this entry.
    Sequence similarity: Belongs to the immunoglobulin superfamily. BTN/MOG family. {ECO:0000305}.; Contains 1 Ig-like V-type (immunoglobulin-like) domain. {ECO:0000305}.
    General information above from UniProt

    Myelin oligodendrocyte glycoprotein (MOG) is a transmembrane protein belonging to immunoglobulin superfamily, and contains an Ig-like domain followed by two potential membrane-spanning regions. MOG is expressed only in the CNS with very low content (approximately 0.1% total proteins) in oligodendrogliocyte membrane. Three possible functions for MOG were suggested: (a) a cellular adhesive molecule, (b) a regulator of oligodendrocyte microtubule stability, and (c) a mediator of interactions between myelin and the immune system, in particular, the complement cascade. A direct interaction might exist between the membrane-associated regions of MOG and the myelin-specific glycolipid galactocerebroside (Gal-C), and such an interaction may have important consequences regarding the membrane topology and function of both molecules. It is considered that MOG is an autoantigen capable to produce a demyelinating multiple sclerosis-like disease in experimental animals.

    Myelin oligodendrocyte glycoprotein Alternative Name

    BTN6,BTNL11,MOGIG2,NRCLP7, [homo-sapiens]
    DAQB-92E24.2,MGC26137,MOG,MOGIG2, [human]
    B230317G11Rik,Mog, [mouse]
    B230317G11Rik, [mus-musculus]

    Myelin oligodendrocyte glycoprotein Related Studies

  • Chekhonin VP, et al. (2003) Myelin oligodendrogliocyte glycoprotein: the structure, functions, role in pathogenesis of demyelinating disorders. Biomed Khim. 49(5): 411-23.
  • Hilton AA, et al. (1995) Characterization of cDNA and Genomic Clones Encoding Human Myelin Oligodendrocyte Glycoprotein. J Neurochem. 65(1): 309-18.
  • Johns TG, et al. (1999) The Structure and Function of Myelin Oligodendrocyte Glycoprotein. J Neurochem. 72(1): 1-9.
  • Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"